Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
The Cochrane Database of Systematic Reviews|October 19, 2007
Antidepressants for neuropathic painT Saarto, P J Wiffen
The Cochrane Database of Systematic Reviews|July 22, 2005
Antidepressants for neuropathic painT Saarto, P J Wiffen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trialT Saarto, C Blomqvist, P Virkkunen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 23, 2011
Breast cancer in very young womenS Liukkonen, M Leidenius, T Saarto, et al.
British Journal of Cancer|September 1, 1999
Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMFP Poikonen, T Saarto, J Lundin, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patientsP Poikonen, T Saarto, I Elomaa, et al.
Breast Cancer Research and Treatment|April 2, 2005
Clodronate treatment influences MMP-2 associated outcome in node positive breast cancerS Leppä, T Saarto, L Vehmanen, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 17, 2017
End-of-life care pathway of head and neck cancer patients: single-institution experienceT Heinonen, V Loimu, K Saarilahti, et al.
British Journal of Cancer|January 1, 1997
Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancerT Saarto, C Blomqvist, P Rissanen, et al.
Calcified Tissue International|August 3, 2005
Three-year oral clodronate treatment does not impair mineralization of newly formed bone--a histomorphometric studyT Saarto, T Taube, C Blomqvist, et al.
Pageof 4